These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 29405696

  • 1. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
    Miranda PO, Cubitt B, Jacob NT, Janda KD, de la Torre JC.
    ACS Infect Dis; 2018 May 11; 4(5):815-824. PubMed ID: 29405696
    [Abstract] [Full Text] [Related]

  • 2. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
    Ngo N, Henthorn KS, Cisneros MI, Cubitt B, Iwasaki M, de la Torre JC, Lama J.
    J Virol; 2015 Nov 11; 89(21):10924-33. PubMed ID: 26292327
    [Abstract] [Full Text] [Related]

  • 3. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
    Cheng BY, Ortiz-Riaño E, Nogales A, de la Torre JC, Martínez-Sobrido L.
    J Virol; 2015 Apr 11; 89(7):3523-33. PubMed ID: 25589652
    [Abstract] [Full Text] [Related]

  • 4. A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding.
    Capul AA, de la Torre JC.
    Virology; 2008 Dec 05; 382(1):107-14. PubMed ID: 18929379
    [Abstract] [Full Text] [Related]

  • 5. Reverse genetics approaches to combat pathogenic arenaviruses.
    de la Torre JC.
    Antiviral Res; 2008 Dec 05; 80(3):239-50. PubMed ID: 18782590
    [Abstract] [Full Text] [Related]

  • 6. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    de la Torre JC.
    Ann N Y Acad Sci; 2009 Sep 05; 1171 Suppl 1():E57-64. PubMed ID: 19751403
    [Abstract] [Full Text] [Related]

  • 7. The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.
    Kim YJ, Cubitt B, Chen E, Hull MV, Chatterjee AK, Cai Y, Kuhn JH, de la Torre JC.
    Antiviral Res; 2019 Sep 05; 169():104558. PubMed ID: 31302150
    [Abstract] [Full Text] [Related]

  • 8. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G, Trofimenko E, Mayor J, Fedeli C, Moreno H, Michel S, Heulot M, Chevalier N, Zimmer G, Shrestha N, Plattet P, Engler O, Rothenberger S, Widmann C, Kunz S.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30626681
    [Abstract] [Full Text] [Related]

  • 9. Arenavirus extinction through lethal mutagenesis.
    de la Torre JC.
    Virus Res; 2005 Feb 15; 107(2):207-14. PubMed ID: 15649566
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
    Ortiz-Riaño E, Ngo N, Devito S, Eggink D, Munger J, Shaw ML, de la Torre JC, Martínez-Sobrido L.
    J Virol; 2014 Jan 15; 88(2):878-89. PubMed ID: 24198417
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid.
    Vázquez-Calvo Á, Martín-Acebes MA, Sáiz JC, Ngo N, Sobrino F, de la Torre JC.
    Antiviral Res; 2013 Aug 15; 99(2):172-9. PubMed ID: 23735299
    [Abstract] [Full Text] [Related]

  • 12. General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines.
    Iwasaki M, Ngo N, Cubitt B, Teijaro JR, de la Torre JC.
    J Virol; 2015 Dec 15; 89(23):12166-77. PubMed ID: 26401045
    [Abstract] [Full Text] [Related]

  • 13. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
    Cheng BY, Ortiz-Riaño E, de la Torre JC, Martínez-Sobrido L.
    J Virol; 2015 Jul 15; 89(14):7373-84. PubMed ID: 25972555
    [Abstract] [Full Text] [Related]

  • 14. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease.
    Urata S, Yun N, Pasquato A, Paessler S, Kunz S, de la Torre JC.
    J Virol; 2011 Jan 15; 85(2):795-803. PubMed ID: 21068251
    [Abstract] [Full Text] [Related]

  • 15. Sodium hydrogen exchangers contribute to arenavirus cell entry.
    Iwasaki M, Ngo N, de la Torre JC.
    J Virol; 2014 Jan 15; 88(1):643-54. PubMed ID: 24173224
    [Abstract] [Full Text] [Related]

  • 16. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
    Neuman BW, Bederka LH, Stein DA, Ting JP, Moulton HM, Buchmeier MJ.
    Antimicrob Agents Chemother; 2011 Oct 15; 55(10):4631-8. PubMed ID: 21825302
    [Abstract] [Full Text] [Related]

  • 17. The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.
    Iwasaki M, Cubitt B, Sullivan BM, de la Torre JC.
    J Virol; 2016 Jan 06; 90(6):3187-97. PubMed ID: 26739049
    [Abstract] [Full Text] [Related]

  • 18. Novel antiviral strategies to combat human Arenavirus infections.
    Kunz S, de la Torre JC.
    Curr Mol Med; 2005 Dec 06; 5(8):735-51. PubMed ID: 16375709
    [Abstract] [Full Text] [Related]

  • 19. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).
    Ruiz-Jarabo CM, Ly C, Domingo E, de la Torre JC.
    Virology; 2003 Mar 30; 308(1):37-47. PubMed ID: 12706088
    [Abstract] [Full Text] [Related]

  • 20. Arenavirus Quasispecies and Their Biological Implications.
    Grande-Pérez A, Martin V, Moreno H, de la Torre JC.
    Curr Top Microbiol Immunol; 2016 Mar 30; 392():231-76. PubMed ID: 26472215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.